Article
Neutralizing Antibodies Targeting HIV-1 gp41.
Viruses - 23 Oct 2020
Caillat Christophe, Guilligay Delphine, Sulbaran Guidenn, Weissenhorn Winfried
Abstract excerpt
HIV-1 vaccine research has obtained an enormous boost since the discovery of many broadly neutralizing antibodies (bnAbs) targeting all accessible sites on the HIV-1 envelope glycoprotein (Env). This in turn facilitated high-resolution structures of the Env glycoprotein in complex with bnAbs. Here we focus on gp41, its highly conserved heptad repeat region 1 (HR1), the fusion peptide (FP) and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
